HSD17B13 and metabolic dysfunction-associated steatotic liver disease: Although murine models have produced inconsistent results, human GWAS studies have uncovered robust and reproducible associations between HSD17B13 gene variations and the natural history of NAFLD/NASH (Anstee et al., 2020).